Aurio Pharma Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.68 M
as on 16-11-2024
- Company Age 26 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.87 Cr
as on 16-11-2024
- Satisfied Charges ₹ 3.00 Cr
as on 16-11-2024
- Revenue 11.46%
(FY 2023)
- Profit -86.38%
(FY 2023)
- Ebitda -48.67%
(FY 2023)
- Net Worth 5.73%
(FY 2023)
- Total Assets -9.52%
(FY 2023)
About Aurio Pharma Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.68 M.
The company currently has active open charges totaling ₹5.87 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Santosh Bhattacharya and Mandira Bhattacharjee serve as directors at the Company.
- CIN/LLPIN
U85195WB1998PTC086879
- Company No.
086879
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Aurio Pharma Laboratories Private Limited offer?
Aurio Pharma Laboratories Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Antipyretic Medication, Paracetamol Tablets, Body Care Products, Body Oil, Child and Baby Care Products, Baby Oil, Multivitamin Syrup & Drops, Common Disease Medicines.
Who are the key members and board of directors at Aurio Pharma Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Bhattacharya  | Director | 30-Mar-1998 | Current |
| Mandira Bhattacharjee | Director | 18-Aug-1999 | Current |
Financial Performance of Aurio Pharma Laboratories.
Aurio Pharma Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.46% increase. The company also saw a substantial fall in profitability, with a 86.38% decrease in profit. The company's net worth moved up by a moderate rise of 5.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurio Pharma Laboratories?
In 2023, Aurio Pharma Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ram Lal Laboratories Private LimitedActive 27 years 11 monthsSantosh Bhattacharya and Mandira Bhattacharjee are mutual person
- Kingfisher East Bengal Football Team Private LimitedActive 26 years 9 months
Santosh Bhattacharya is a mutual person
- Classic Designer & Developer Pvt.Ltd.Active 29 years 2 months
Mandira Bhattacharjee is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 30 Jun 2018 | ₹5.87 Cr | Open |
Bank Of Baroda Creation Date: 22 Jun 1998 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Aurio Pharma Laboratories?
Aurio Pharma Laboratories has a workforce of 114 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurio Pharma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurio Pharma Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
